Tobramycin and diarrhoea Patient Reports February 12, 2012

Tobramycin Side Effects Report #4970770-2
Tobramycin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 08, 2005. Female patient, 66 years of age, weighting 135.0 lb, was diagnosed with kidney infection, pseudomonas infection and was treated with Tobramycin. After drug was administered, patient experienced the following side effects: diarrhoea, nausea , pyrexia. Tobramycin dosage: 300 MILLIGRAM INTRAVENOUS (NOS). Patient was hospitalized. Patient recovered.

Tobramycin Side Effects Report #4648433-2
Tobramycin side effect was reported by a Physician from on Apr 13, 2005. Female patient, 20 years of age, was diagnosed with inflammation, staphylococcal infection  and was treated with Tobramycin. After drug was administered, patient experienced the following side effects: diarrhoea, increased upper airway secretion, red man syndrome, staphylococcal infection , toxic epidermal necrolysis. Tobramycin dosage: unknown. During the same period patient was treated with VANCOMYCIN, VALPROATE, FLOMOXEF, CEFOZOPRAN, GALENIC. Patient was hospitalized. Patient recovered.

Tobramycin Side Effects Report #4673915-7
Tobramycin side effect was reported by a Physician from on May 06, 2005. Female patient, 20 years of age, was diagnosed with inflammation, staphylococcal infection  and was treated with Tobramycin. After drug was administered, patient experienced the following side effects: diarrhoea, haemorrhagic diathesis, increased upper airway secretion, pyrexia, red man syndrome, staphylococcal infection , toxic epidermal necrolysis. Tobramycin dosage: unknown. During the same period patient was treated with VANCOMYCIN, VALPROATE, FLOMOXEF, CEFOZOPRAN, GALENIC, ARBEKACIN. Patient was hospitalized. Patient recovered.

Tobramycin Side Effects Report #4752377-5
Tobramycin side effect was reported by a Physician from FRANCE on Aug 09, 2005. Female patient, 31 years of age, weighting 346.1 lb, was diagnosed with infection  and was treated with Tobramycin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood bilirubin increased, diarrhoea, gamma-glutamyltransferase increased, hepatocellular damage. Tobramycin dosage: 175 MG DAY. During the same period patient was treated with TAZOCILLINE, PROGRAF, CELLCEPT, KARDEGIC, LEXOMIL, PAROXETINE HYDROCHLORIDE, SERETIDE, IDEOS. Patient was hospitalized. Patient recovered.